drugset / Trial / NCT05001243
Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety and Efficacy of Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac (PBOHB) ophthalmic compound compared to Pilocarpine and Brimonidine to improve uncorrected near vision in healthy presbyopic patients one hour after instillation.
Timeline
- Start
- 2021-08-10
- Primary completion
- 2021-08-30
- Completion
- 2021-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Unknown | 0.5 mg | Other |
| Comparator | Bromfenac | Other / unclassified | — | Other |
| Comparator | Hyaluronic Acid | Other / unclassified | — | Other |
| Comparator | Oxymetazoline | Other / unclassified | — | Other |
| Comparator | Pilocarpine | Unknown | 5 mg | Other |